PMC17 RASCH ANALYSIS OF THE FATIGUE IMPACT SCALE  by Meads, DM et al.
A70 Abstracts
PMC17
RASCH ANALYSIS OF THE FATIGUE IMPACT SCALE
Meads DM1, Hampson NE1, Fisk JD2, McKenna SP1, Doward LC1,
Mayo KW3
1Galen Research, Manchester, Manchester, UK; 2Dalhousie University,
Halifax, Nova Scotia, Canada; 3Novartis Pharma AG, Basel, Basel,
Switzerland
OBJECTIVES: The Fatigue Impact Scale (FIS) is a 40-item mul-
tiple response questionnaire designed to assess fatigue, divided
into cognitive, physical, and psychosocial functioning subscales.
The purpose of the study was to improve the measure by remov-
ing differential item functioning (DIF) and reducing the number
of items. METHODS: FIS data were available from 188 patients
with multiple sclerosis (MS). These data were subjected to Rasch
analysis (one-parameter logistic item response theory) using the
RUMM programme. Fit to the Rasch model was examined via
Chi2 statistics and assessments of DIF related to gender, age and
MS type. RESULTS: FIS responses from the 188 MS patients
were analysed (47/25% male; mean age 50.9, SD 10.5; 39.6%
relapsing remitting, 36.9% primary progressive, 23.5% sec-
ondary progressive). Initial results showed that the 40-item FIS
exhibited misﬁt and was not unidimensional. Several items
exhibited DIF by age, gender or MS-type. For example, patients
aged over 50 years scored signiﬁcantly higher than patients aged
50 or younger (who had a similar level of fatigue) on the item
“I have to rely more on others to help me”. DIF by MS-type indi-
cated that answers to certain items are signiﬁcantly inﬂuenced
by the disease stage of the patient. After the removal of 9 items
that either misﬁt or exhibited age or gender DIF, the reduced FIS
ﬁt the Rasch model (Chi2 p > 0.05), providing a unidimensional
fatigue scale. The threshold map suggests that for some items the
response categories did not discriminate in the way intended,
suggesting that changing the response format may improve the
scale. CONCLUSIONS: The analysis showed that it is feasible
to derive a single unidimensional scale of fatigue from the FIS.
The severity (logit) coverage of the scale is good but there
remains item redundancy suggesting further scope for item
reduction.
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PSYCHOMETRIC PROPERTIES OF A TOUCH SCREEN
COMPUTER-BASED VERSION OF THE SF-36
Ramachandran S1,Taber T2, Coons SJ1
1University of Arizona,Tucson, AZ, USA; 2Assist Technologies,
Scottsdale, AZ, USA
OBJECTIVES: The purpose of this study was to examine the
psychometric properties of a touch screen version (Assist Tech-
nologies) of the SF-36, a widely used measure of self-reported
health status. METHODS: Non-probability purposive sampling
was used to recruit 300 subjects intended to reﬂect the primary
socio-demographic characteristics of the US general adult popu-
lation. The SF-36 was administered via touch screen along with
the EQ-5D and other items. Amount of missing data and pres-
ence of ﬂoor and ceiling effects were assessed. Scale score inter-
nal consistency was estimated using Cronbach’s alpha
coefﬁcient. As one test of construct validity, mean scale scores
were compared across groups known to differ in regard to pres-
ence of chronic conditions. Convergent and discriminant 
construct validity were evaluated through examination of corre-
lations between SF-36 scales and the EQ-5D domains.
RESULTS: A total of 312 respondents completed the study. Scale
means and standard deviations for the touch screen SF-36 in this
sample were very similar to those seen with the paper-based
format in the US general population. Less than 1% of all
responses were missing. The percentage of respondents at the
ﬂoor for almost all scales was less than 10%. Ceiling effects were
evident for several of the scales. In general, these ﬂoor and ceiling
effects were very similar to that observed in the general US pop-
ulation. All of the reliability coefﬁcients exceeded 0.70; the range
was from 0.75 to 0.93. Respondents with one or more chronic
conditions reported signiﬁcantly lower scores on all eight scales
of the SF-36 compared to those with no chronic conditions. The
direction and strength of the correlations between the SF-36
scales and the EQ-5D domains were as hypothesized. CON-
CLUSION: The comparable psychometric properties and lower
levels of missing data make this touch screen version a very
viable alternative to the paper-based SF-36 format.
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HOW LONG AGO . . . ?: ASSESSING PATIENT ADHERENCE TO
SPECIFIED QUESTIONNAIRE RECALL PERIODS
Coyne KS, Brewster-Jordan J
The MEDTAP Institute at UBC, Bethesda, MD, USA
OBJECTIVES: Patient-reported outcome (PRO) measures are
typically designed to instruct patients to consider a speciﬁc time-
frame (recall period) when answering each item. Recall periods
vary in length (i.e., 24 hours, 1 week, or 4 weeks) based upon
the condition being assessed and the objectives of the research.
The goal of this study was to assess patient adherence patterns
to recall periods varying in duration by analyzing summaries of
one-on-one qualitative patient interviews. METHODS: Data
were reviewed from eight previously conducted cognitive
debrieﬁng interviews on condition speciﬁc measures that varied
in recall period length. In all interviews, patients were speciﬁ-
cally asked what recall period they had used when completing
the PRO measure. The patient’s response and the questionnaire’s
prespeciﬁed recall period were compared. RESULTS: Cognitive
debrieﬁng data for 115 patients (55% women) with a mean age
of 57.1 was reviewed. The conditions of the ten PROs evaluated
were: GERD (n = 2), Dementia (n = 2), Diabetes (n = 3), and
Overactive Bladder (n = 3). Recall periods were: Daily (n = 1);
1 week (n = 2); 2 weeks (n = 2); 2 to 4 weeks (n = 1); and 4
weeks (n = 4). The majority of patients (57.9%) stated the recall
period speciﬁed on the PRO measure; 14.5% recalled a general
period of time (e.g. since they had the condition); 13.8% stated
a time over the recall period while 12.6% stated a time under
the recall period. Shorter recall periods (e.g. 1 week) had more
concordant patient responses than longer recall periods (80% vs.
53%). CONCLUSIONS: Patients tend to adhere better to
shorter recall periods than longer recall periods when complet-
ing PRO measures. Questionnaires with longer recall periods
often result with patients thinking in general terms of their con-
dition or using a recall period of their own.
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INDIRECT COMPARISON (OR COMMON-COMPARATOR)
METHODS FOR META-ANALYSIS OF SUMMARY DATA
Fitzgerald P, LeReun C,Aristides M
M-TAG, A division of IMS Health Economics and Outcomes
Research, London, UK
OBJECTIVES: In this presentation we summarise statistical
methods for meta-analysis when a direct comparison between
treatment effects is impossible, inadequate, or inappropriate.
METHODS: Detailed descriptions are presented, and these are
appraised per se and in relation with conventional meta-analy-
sis methods. The main methods can be summarised as follows:
weighted mean difference of relative effect measures (e.g. mean
difference, log-odds-ratio, log-relative-risk and log-hazard-ratio)
and meta-regression of relative effect measures, both of which
are based on traditional meta-analysis approaches, and weighted
